Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Plasmacytoma × Granulocyte Colony-Stimulating Factor × Clear all

Sponsor

Conditions

Multiple Myeloma 45 Leukemia, Myeloid, Acute 39 Lymphoma, Non-Hodgkin 37 Precursor Cell Lymphoblastic Leukemia-Lymphoma 32 Lymphoma 31 Hodgkin Disease 30 Myelodysplastic Syndromes 26 Leukemia 26 Lymphoma, Mantle-Cell 19 Leukemia, Lymphocytic, Chronic, B-Cell 18 Lymphoma, Large B-Cell, Diffuse 17 Burkitt Lymphoma 15 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 14 Lymphoma, Follicular 12 Lymphoma, B-Cell, Marginal Zone 10 Hematologic Neoplasms 10 Neoplasms, Plasma Cell 9 Leukemia, Biphenotypic, Acute 9 Congenital Abnormalities 9 Breast Neoplasms 9 Lymphoma, Large-Cell, Immunoblastic 8 Recurrence 7 Leukemia, Myelomonocytic, Juvenile 7 Leukemia, Myelomonocytic, Chronic 7 Anemia, Refractory, with Excess of Blasts 7 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 6 Neuroblastoma 6 Myeloproliferative Disorders 6 Sarcoma 5 Primary Myelofibrosis 5

Interventions

Dexamethasone 3 dexamethasone acetate 2 dexamethasone 21-phosphate 2 auricularum 2 Calcium Dobesilate 2 Bortezomib 2 pomalidomide 1 navtemadlin; 2-((3R,5R,6S)-5-(3-chlorophenyl)-6-(4-chlorophenyl)-1-((S)-1-(isopropylsulfonyl)-3-methylbutan-2-yl)-3-methyl-2-oxopiperidin-3-yl)acetic acid 1 ixazomib 1 daratumumab 1 carfilzomib 1 Specimen Handling 1 Peripheral Blood Stem Cell Transplantation 1 Panobinostat 1 Melphalan 1 Lenalidomide 1 Gemcitabine 1 Busulfan 1 Biopsy 1 2-(5-(3-chlorophenyl)-6-(4-chlorophenyl)-1-(1-(isopropylsulfonyl)-3-methylbutan-2-yl)-3-methyl-2-oxopiperidin-3-yl)acetic acid 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡